{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/briefmesoblast-says-co--lonza-enter-agreement-for-commercial-manufacture-of-cos-allogeneic-cell-therapy-1973713", "downloaded_at": "2019-10-17 01:50:29.810616+00:00", "title": "BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy", "language": "en", "text": "BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy\n\nStock Markets 8 minutes ago (Oct 17, 2019 12:42)\n\n\u00a9 Reuters. BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy Oct 17 (Reuters) - Mesoblast : * CO & LONZA ENTER AGREEMENT FOR COMMERCIAL MANUFACTURE OF MESOBLAST'S POTENTIAL FIRST UNITED STATES ALLOGENEIC CELL THERAPY * EXPECTS TO COMPLETE FILING OF ROLLING BIOLOGICS LICENSE APPLICATION SUBMISSION TO US FDA BY THE END OF THIS YEAR\n\nBRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy", "description": "BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB65083_L.jpg", "published_at": "2019-10-17"}